<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02371343</url>
  </required_header>
  <id_info>
    <org_study_id>SamiUlusCH</org_study_id>
    <nct_id>NCT02371343</nct_id>
  </id_info>
  <brief_title>Fish Oil Supplementation in Women With Gestational Diabetes</brief_title>
  <official_title>Effect of Fish Oil Supplementation in Women With Gestational Diabetes on Insulin Like Growth Factor-1 DNA Methylation in Newborns</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Dr. Sami Ulus Children's Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Dr. Sami Ulus Children's Hospital</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Gestational diabetes is the development of diabetes during pregnancy. Left untreated,&#xD;
      gestational diabetes and preeclampsia can lead to serious -- or even fatal -- complications&#xD;
      for both mother and child. Some evidence suggesting omega-3 fatty acids might help protect&#xD;
      women from two serious pregnancy complications -- gestational diabetes and preeclampsia.&#xD;
      Omega-3 fatty acids, in particular Docosahexaenoic acid (DHA), help a pregnant woman give her&#xD;
      developing baby every advantage in life starting in-utero. Recent studies suggested that the&#xD;
      biologic processes underlying the observed associations may involve epigenetic changes,&#xD;
      specifically DNA methylation. In this study the investigators aimed to examine the effect of&#xD;
      fish oil supplementation in women with gestational diabetes mellitus on newborn outcomes and&#xD;
      insulin like growth factor 1 DNA methylation.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Gestational diabetes is the development of diabetes during pregnancy. According to the&#xD;
      National Institutes of Health, gestational diabetes occurs in about 5 percent of all&#xD;
      pregnancies in the United States, resulting in about 200,000 cases a year. Treatment involves&#xD;
      dietary measures, exercise and, in some cases, insulin injections. All pregnant women should&#xD;
      be taking a prescribed pre-natal vitamin, and should also supplement with fish oil or another&#xD;
      source of omega-3 fatty acids to help support the nervous system of their developing child.&#xD;
&#xD;
      Left untreated, gestational diabetes and preeclampsia can lead to serious -- or even fatal --&#xD;
      complications for both mother and child. In diabetic pregnancies there is an increased risk&#xD;
      of birth defects. Some evidence suggesting omega-3 fatty acids might help protect women from&#xD;
      two serious pregnancy complications -- gestational diabetes and preeclampsia. Omega-3 fatty&#xD;
      acids, in particular Docosahexaenoic acid (DHA), help a pregnant woman give her developing&#xD;
      baby every advantage in life starting in-utero. In general the omega-3 fatty acids found in&#xD;
      fish help the cardiovascular system, the brain (including moods), and even the brain and eyes&#xD;
      of a developing baby. The risk of pre-term delivery and low birth weight is three and a half&#xD;
      times higher when mothers are deficient in DHA. Recent studies suggested that the biologic&#xD;
      processes underlying the observed associations may involve epigenetic changes, specifically&#xD;
      DNA methylation. In this study the investigators aimed to examine the effect of fish oil&#xD;
      supplementation in women with gestational diabetes mellitus on newborn outcomes and insulin&#xD;
      like growth factor 1 DNA methylation.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Not yet recruiting</last_known_status>
  <start_date>March 2015</start_date>
  <completion_date type="Anticipated">September 2016</completion_date>
  <primary_completion_date type="Anticipated">March 2016</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Prevention</primary_purpose>
    <masking>Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Birth size</measure>
    <time_frame>1 year</time_frame>
    <description>Birth size of the newborns</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Insulin like growth factor DNA methylation</measure>
    <time_frame>1 year</time_frame>
    <description>Insulin like growth factor DNA methylation</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">100</enrollment>
  <condition>Fetal Macrosomia</condition>
  <condition>Congenital Abnormality</condition>
  <condition>Other Respiratory Problems After Birth</condition>
  <arm_group>
    <arm_group_label>Fish-Oil</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>The pregnants with gestational diabetes given fish oil:&#xD;
(Ocean Plus, 1200 mg, EPA 384 mg DHA 252 mg, total omega-3 782 mg, 50 soft gel, Ocean®, German) During third trimester of pregnancy, Once in a day</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Sunflower oil</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>The pregnants with gestational diabetes given sunflower oil:&#xD;
Sunflower oil capsules will be prepared in the pharmacy as the same size and colour with fish oil capsules During third trimester of pregnancy, Once in a day</description>
  </arm_group>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>Fish oil, Ocean plus</intervention_name>
    <description>Ocean Plus, 1200 mg, EPA 384 mg DHA 252 mg, total omega-3 782 mg, 50 soft gel, Ocean®, Germany</description>
    <arm_group_label>Fish-Oil</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>Sunflower Oil</intervention_name>
    <arm_group_label>Sunflower oil</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Women who were diagnosed as gestational diabetes mellitus (GDM) between 24 and 28th&#xD;
             week of pregnancy&#xD;
&#xD;
          -  Women with GDM and accepted to be participate in the study&#xD;
&#xD;
          -  Women younger that 40 years old&#xD;
&#xD;
          -  The newborns of the women with GDM&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  The history of Type 1 diabetes melitus&#xD;
&#xD;
          -  Abnormal glucose tolerance &lt;20th gestational week&#xD;
&#xD;
          -  The history of chronic illness in the mother&#xD;
&#xD;
          -  Women who eat fish &lt;2 times in a week&#xD;
&#xD;
          -  Any history of sea-food allergy in the mother&#xD;
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>20 Years</minimum_age>
    <maximum_age>40 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Dilek Dilli, Assoc Prof</last_name>
    <role>Principal Investigator</role>
    <affiliation>Teaching assistant</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Dilek Dilli, Assoc Prof</last_name>
    <phone>+905422368250</phone>
    <email>dilekdilli2@yahoo.com</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Nazan Doğan, MD</last_name>
    <phone>+903123055000</phone>
    <phone_ext>6284</phone_ext>
    <email>nazanneslihan@hotmail.com</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Sami Ulus CH</name>
      <address>
        <city>Ankara</city>
        <zip>06120</zip>
        <country>Turkey</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Turkey</country>
  </location_countries>
  <results_reference>
    <citation>Guermouche B, Soulimane-Mokhtari NA, Bouanane S, Merzouk H, Merzouk S, Narce M. Effect of dietary n - 3 polyunsaturated fatty acids on oxidant/antioxidant status in macrosomic offspring of diabetic rats. Biomed Res Int. 2014;2014:368107. doi: 10.1155/2014/368107. Epub 2014 Jun 2.</citation>
    <PMID>24987679</PMID>
  </results_reference>
  <results_reference>
    <citation>Soulimane-Mokhtari NA, Guermouche B, Yessoufou A, Saker M, Moutairou K, Hichami A, Merzouk H, Khan NA. Modulation of lipid metabolism by n-3 polyunsaturated fatty acids in gestational diabetic rats and their macrosomic offspring. Clin Sci (Lond). 2005 Sep;109(3):287-95.</citation>
    <PMID>15898958</PMID>
  </results_reference>
  <verification_date>February 2015</verification_date>
  <study_first_submitted>February 19, 2015</study_first_submitted>
  <study_first_submitted_qc>February 24, 2015</study_first_submitted_qc>
  <study_first_posted type="Estimate">February 25, 2015</study_first_posted>
  <last_update_submitted>February 24, 2015</last_update_submitted>
  <last_update_submitted_qc>February 24, 2015</last_update_submitted_qc>
  <last_update_posted type="Estimate">February 25, 2015</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Dr. Sami Ulus Children's Hospital</investigator_affiliation>
    <investigator_full_name>Dilek Dilli</investigator_full_name>
    <investigator_title>Dilek Dilli, MD</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Diabetes, Gestational</mesh_term>
    <mesh_term>Fetal Macrosomia</mesh_term>
    <mesh_term>Congenital Abnormalities</mesh_term>
  </condition_browse>
  <pending_results>
    <submitted>April 22, 2017</submitted>
    <returned>July 18, 2017</returned>
  </pending_results>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

